Raymond Wadlow, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    Colorectal Cancer
    Date added:
    04/24/2023
    Date updated:
    03/07/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Exact Sciences
    Topic:
    Colorectal Cancer
    Date added:
    04/24/2023
    Date updated:
    03/07/2024
    Relationship end date:
    01/25/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Taiho
    Topic:
    Colorectal Cancer
    Date added:
    04/24/2023
    Date updated:
    03/07/2024
    Relationship end date:
    03/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Seagen
    Topic:
    Colorectal Cancer
    Date added:
    04/24/2023
    Date updated:
    03/07/2024
    Relationship end date:
    10/25/2022
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Pfizer
    Topic:
    Colorectal Cancer
    Date added:
    04/24/2023
    Date updated:
    03/07/2024
    Relationship end date:
    12/31/2023
Return to Sept. 27-28, 2024 - Symposium for Evolving Therapies and Drug Development in Oncology